Fidelis Capital Partners, LLC Ptc Therapeutics, Inc. Transaction History
Fidelis Capital Partners, LLC
- $654 Billion
- Q1 2024
A detailed history of Fidelis Capital Partners, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 842 shares of PTCT stock, worth $27,474. This represents 0.05% of its overall portfolio holdings.
Number of Shares
842Holding current value
$27,474% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding PTCT
# of Institutions
200Shares Held
83.9MCall Options Held
192KPut Options Held
129K-
Vanguard Group Inc Valley Forge, PA9.37MShares$306 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.9MShares$290 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.57MShares$247 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.42MShares$242 Million3.47% of portfolio
-
Armistice Capital, LLC New York, NY6.76MShares$221 Million2.68% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $2.33B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...